Jin Yin is currently the VP of Process Development at Oxford Biomedica, specializing in AAV and LV. Prior to this role, Jin held positions at Homology Medicines, Inc., Momenta Pharmaceuticals, Sanofi Genzyme, Shire, ID Biomedical / GSK Biologicals, and Massachusetts Institute of Technology, focusing on various aspects of bioprocessing, cell culture process development, and manufacturing support in the biopharmaceutical industry. Jin holds a B.S. and Ph.D. in Chemical Engineering from Tsinghua University.
January, 2023 - present
March, 2022